Medical officer
National Institute of Child Health and Human Development
Bethesda, Maryland, United States
Dr. Monica Longo is an Obstetrician-Gynecologist and a Maternal Fetal Medicine. She holds a PhD degree in Preventive Medicine and Community Health. Dr. Longo’s main research focus on the maternal physiological adaptations to pregnancy, and in particular the relationship with cardiovascular and metabolic disease in the mother and offspring later in life. Dr. Longo received her medical degree in 1996 from the Faculty of Medicine in Modena, Italy. In June 1997, she joined the research team at the University of Texas Medical Branch at Galveston (UTMB) where she earned her Master and PhD degrees, followed by residency training in OB/GYN. At UTMB, she received funding from NHLBI and NICHD to developed a novel transgenic animal model of fetal programming, showing that utero-placental insufficiency alters vascular function in the adult offspring independent of genetic predisposition. In 2013, Dr. Longo joined the Department of Ob/GYN at the University of Texas Health Science Center at Houston (UTHSC) where she established a basic science research laboratory focusing on pregnancy complications using animal models. While at UTHSC, Dr. Longo pursued fellowship training in Maternal Fetal Medicine. Most recently, she collaborated with industry on development and clinical validation of a rapid point-of-care test for COVID antibodies in pregnant and non-pregnant individuals. Throughout her career, Dr. Longo has mentored several graduate students, fellows, residents, and faculty. Her research has received awards at national and international meetings, including the Society for Maternal Fetal Medicine and the Society for Reproductive Investigation. Dr. Longo has also served on various scientific review panels, including NIH study sections, and has been a reviewer for high-impact journals. By focusing on pregnancy, Dr. Longo’s ultimate career goal is to improve outcome for mothers and children throughout the lifespan from preconception to later in life, main reason for her to join NICHD in January 2021.
(43) Pravastatin dose-range and pharmacokinetic study in a pregnant rat model
Friday, January 31, 2025
9:00 AM - 9:15 AM